In this studry 32 hyperglycemic patients with type II DM were treated with diet (7 patients), with gliclazide, an oral antidiabetic agent (10 patients), or with insulin (15 patients). The levels of liporoteins, apolipoprotein A and B and LCAT enzyme are measured before the therapy and 3 weeks after the achievement of glycemic control. Treatment types are compared with each other and with control group (10 normal persons) triglyseride (TG) and VLDL levels which were found to be high in all of the patients decreased in all groups to levels similar to control group. TC (total cholesterol), LDL, TC/HDL, LDL/HDL levels found high before treatment in the OAD (oral antidiabetic) group (p
Diabetes Mellitus, Plasma Lipoproteins, Apolipoproteins, LCAT.
VARDARELİ, Eser; EFE, Belgin; AKYÜZ, Fahrettin; İNAL, Mine; and ERENOĞLU, Esat (1998) "The Effect of Treatment Types on Plasma Levelsof Lipoproteins, Apolipoproteins and LCAT inType II Diabetes Mellitus," Turkish Journal of Medical Sciences: Vol. 28: No. 4, Article 17. Available at: https://journals.tubitak.gov.tr/medical/vol28/iss4/17